On December 28, 2023, Cytogen, Inc. closed the transaction. The company received KRW 15,500,000,000 for series 5 bonds in its second and final tranche closing.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,770 KRW | +4.16% | -2.69% | -27.74% |
1st Jan change | Capi. | |
---|---|---|
-27.74% | 153M | |
+10.78% | 3.43B | |
+2.21% | 2.27B | |
-19.52% | 2.03B | |
-20.03% | 1.63B | |
+33.28% | 1.16B | |
+17.92% | 714M | |
-9.39% | 703M | |
-23.27% | 500M | |
-1.29% | 279M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited